Resting 123I-BMIPP scintigraphy in diagnosis of effort angina pectoris with reference to subsets of the disease

Annals of Nuclear Medicine

Volumn 12, Issue 3, 1998, Pages 139-144

  Yamabe, Hiroshi ^a   Abe, Hiroaki ^a   Yokoyama, Mitsuhiro ^a   Shiotani, Hideyuki ^b   Kajiya, Sadashi ^c   Mori, Takao ^d   Hashimoto, Yasunori ^e  

^a KOBE UNIVERSITY   (Japan)

^b HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^c Himeji Cardiovascular Disease Center

^d Miki City Hospital

^e Rokkoh Island Hospital

Author keywords

123I BMIPP; Stable angina pectoris; Unstable angina pectoris

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; DIAGNOSTIC AGENT; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; RADIOACTIVE IODINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SCINTIANGIOCARDIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANGIOCARDIOGRAPHY; CLASSIFICATION; CORONARY ARTERY DISEASE; DISEASE COURSE; MIDDLE AGED; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; THORAX PAIN;

AGED; ANGINA PECTORIS; CHEST PAIN; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DISEASE PROGRESSION; FATTY ACIDS; FEMALE; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031594966     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164778     Document Type: Article

References (29)

1. Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 15: 685-698, 1972.
2. Schon HR, Schelbert HR, Najafi A, Hansen H, Huang H, Barrio J, Phelps ME. C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. II. Kinetics of C-11 palmitic acid in acutely ischemic myocardium. Am Heart J 103: 548-561, 1982.
3. 11C palmitate. Circulation 64: 689-699, 1981.
4. Knapp FF Jr, Kropp J, Goodman MM, Franken P, Reske SN, Ambrose KR, et al. The development of iodine-123-β-methyl branched fatty acids and their applications in nuclear cardiology. Ann Nucl Med 7: SII-1-SII-14, 1993.
5. Chouraqui P, Maddahi J, Henkin R, Karesh SM, Galie E, Berman DS. Comparison of myocardial imaging with iodine-123-iodophenyl-9-B-methyl pentadecanoic acid and thallium-201 -chloride for assessment of patients with exercise-induced myocardial ischemia. J Nucl Med 32: 447-452, 1991.
6. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: Assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 33: 659-667, 1992.
7. Takeishi Y, Atsumi H, Fujiwara S, Tomoike H. Delayed metabolic recovery of hibernating myocardium after percutaneous transluminal coronary angioplasty: Assessment with iodine-123-β-methyl-p-iodophenyl pentadecanoic acid imaging. J Cardiol 28: 17-25, 1996.
8. Saitoh M, Hasegawa K, Kondoh T, Yanagawa T. Detection of coronary artery disease using 12-lead electrocardiogram and simultaneous dual myocardial imaging with iodine-123-β-methyl iodophenyl pentadecanoic acid (BMIPP) and thallium-201 in patients with unstable angina. Internal Med 34: 1064-1070, 1995.
9. 99mTc-sestamibi. Ann Nucl Med 9: 125-130, 1995.
10. Nakajima K, Shimizu K, Taki J, Uetani Y, Konishi S, Tonami N, et al. Utility of Iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med 36: 1934-1940, 1995.
11. Kurata C, Tawarahara K, Taguchi T, Aoshima S, Kobayashi A, Yamazaki N, et al. Myocardial emission computed tomography with iodine-123-labeled β-methyl-blanched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 33: 6-13, 1992.
12. 123I-BMIPP scintigraphy and left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy. Ann Nucl Med 10: 225-230, 1996.
13. 123I-BMIPP in patients with stable effort angina pectoris. Nucl Med Commun 16: 1002-1008, 1995.
14. Report of the Joint International Society and Federation of Cardiography/World Health Organization Task Force on Standardization of Clinical Nomenclature: Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 59: 607-609, 1979.
15. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith CS, et al. A reporting system on patients evaluated for coronary artery disease: report of the ad hoc committee for grading of coronary artery disease, Council on Cardiovascular Surgery. American Heart Association. Circulation 51: 5-40, 1975.
16. Yamamichi T, Kusuoka H, Morikita K, Shirakami Y, Kurami M, Okano K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 36: 1043-1050, 1995.
17. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analog, iodine-125-15-(p-iodophenyl)3-(R,S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 31: 1818-1822, 1990.
18. Knapp FF Jr, Ambrose KR, Goodmann MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 12: S39-S44, 1986.
19. Kennedy PL, Corbett JR, Kulkarni PV, Wolfe CL, Jansen DE, Hansen CL, et al. Iodine 123-phenylpentadecanoic acid myocardial scintigraphy: usefulness in the identification of myocardial ischemia. Circulation 74: 1007-1015, 1986.
20. Hansen CL, Corbett JR, Pippin JJ, Jansen DE, Kulkarni PV, Ugolin V, et al. Iodine-123 phenylpentadecanoic acid and single photon emission computed tomography in identifying left ventricular regional metabolic abnormalities in patients with coronary heart disease: Comparison with thallium-201 myocardial tomography. J Am Coll Cardiol 12: 78-87, 1988.
21. Tawarahara K, Kurata C, Taguchi T, Aoshima S, Okayama K, Kobayashi A, et al. Simultaneous dual myocardial imaging with iodine-123-β-methyl iodophenyl-pentadecanoic acid (BMIPP) and thallium-201 in patients with coronary heart disease. Jpn Circ J 58: 107-115, 1994.
22. Mori T, Hayakawa M, Hattori K, Awano K, Masuda J, Inatome T, et al. Exercise β-methyl iodophenyl pentadecanoic acid (BMIPP) and resting thallium delayed single photon emission computed tomography (SPECT) in the assessment of ischemia and viability. Jpn Circ J 60: 17-26, 1996.
23. Franken PR, Dendale P, De Geeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and Sestamibi scintigraphy. J Nucl Med 37: 718-722, 1996.
24. Hashimoto A, Nakata T, Tsuchihashi K, Tanaka S, Fujimori K, Iimura O. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol 77: 25-30, 1996.
25. Matsunari I, Saga T, Taki J, Akashi Y, Hirai J, Wakasugi T, et al. Kinetics of iodine-123 BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 35: 1279-1285, 1994.
26. Ahmed WH, Bittl JA, Braunwald E. Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina. Am J Cardiol 72: 544-550, 1993.
27. Bilodeau L, Theroux P, Gregoire J, Gagnon D, Arsenault A. Technetium-99m Sestamibi tomography in patients with spontaneous chest pain: Correlations with clinical, electrocardiographic and angiographic findings. J Am Coll Cardiol 18: 1684-1691, 1991.
28. Varetto T, Cantalupi D, Altieri A, Orlandi C. Emergency room technetium-99m Sestamibi imaging to rule out acute myocardial ischemic events in patients with nondiagnostic electrocardiograms. J Am Coll Cardiol 22: 1804-1808, 1993.
29. Wackers FJ, Lie KI, Liem KL, Sokole ED, Samson G, Schoot JB, et al. Thallium-201 scintigraphy in unstable angina pectoris. Circulation 57: 738-742, 1978.